Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
Formation and Function of the Myofibroblast during Tissue Repair
2007 Standout
Renal transplantation following previous heart, liver, and lung transplantation: An 8-year single-center experience
2001
Impact of intravascular ultrasound in understanding transplant coronary artery disease
1999
The Systemic Amyloidoses
1997 Standout
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
2008 Standout
Predictors and Evolution of Renal Function during 9 Years Following Heart Transplantation
2000
Amyloid Heart Disease
2010
Predictors of renal function following lung or heart-lung transplantation
2002
Exercise Standards for Testing and Training
2013 Standout
Renal Failure in the Recipients of Nonrenal Solid Organ Transplants
1999
HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac Sarcoidosis
2014 Standout
In Situ Detection of Tissue Factor within the Coronary Intima in Rat Cardiac Allograft Vasculopathy
1999
Cytomegalovirus and Lung Transplantation
2004
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients
2002 Standout
Heart Transplantation in a 68-Year-Old Patient with Senile Systemic Amyloidosis
2005
Diagnosis and Management of Cardiac Sarcoidosis
2010
Myocardial fibrin deposits in the first month after transplantation predict subsequent coronary artery disease and graft failure in cardiac allograft recipients
1998
Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial
2002
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Guideline of transthyretin-related hereditary amyloidosis for clinicians
2013 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
2005
Cardiovascular Toxicities of Immunosuppressive Agents
2002
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
2019
The medium-term findings in coronary arteries by intravascular ultrasound in infants and children after heart transplantation
2000
RISKS AND COSTS OF END-STAGE RENAL DISEASE AFTER HEART TRANSPLANTATION1,2
1998
Surveillance for Transplant Coronary Artery Disease in Infant, Child and Adolescent Heart Transplant Recipients: An Intravascular Ultrasound Study
2006
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
2008
Systemic amyloidosis
2015 Standout
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2016 Standout
Molecular regulation of vessel maturation
2003 Standout
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2016 Standout
CYCLOSPORINE-ASSOCIATED END-STAGE NEPHROPATHY AFTER CARDIAC TRANSPLANTATION
1997
Atherosclerosis
2019 Standout
INCIDENCE, PROGRESSION AND FUNCTIONAL SIGNIFICANCE OF CARDIAC ALLOGRAFT VASCULOPATHY AFTER HEART TRANSPLANTATION1
2000
Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection
2005 Standout
Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis
2004 Standout
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients
2003 Standout
Noninvasive assessment of transplant-associated arteriosclerosis
1998
Effect of Pravastatin on Outcomes after Cardiac Transplantation
1995 Standout
Prospective evaluation of peripheral vascular disease in heart transplant recipients
1995
Assessment of Ischemic Heart Disease Using Magnetic Resonance First-Pass Perfusion Imaging
2003
Influenza vaccination in heart transplant recipients
1999
Infection in Solid-Organ Transplant Recipients
2007 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease
2004 Standout
Adenovirus-mediated gene transfer of the β2-adrenergic receptor to donor hearts enhances cardiac function
1999 StandoutNobel
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The Myofibroblast
2007 Standout
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
2009 Standout
Diagnosis and Management of the Cardiac Amyloidoses
2005
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Contribution of Adventitial Fibroblasts to Neointima Formation and Vascular Remodeling
2001
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Mechanical Circulatory Support and Cardiac Transplantation
1998
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
2004 Standout
Task force 3: Recipient guidelines/prioritization
1993
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease
2011 Standout
Impact of Prophylactic Immediate Posttransplant Ganciclovir on Development of Transplant Atherosclerosis
1999
Intravascular Ultrasound
2001
Intracoronary Adenovirus-Mediated Delivery and Overexpression of the β 2 -Adrenergic Receptor in the Heart
2000 StandoutNobel
Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate
2013 StandoutNobel
Vascular Smooth Muscle Cells in Atherosclerosis
2016 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The mechanism of heart failure caused by cardiac allograft rejection
1991
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
2004 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Hypercholesterolaemia and vascular disease after transplantation
1991 StandoutNobel
Prognostic Importance of Intimal Thickness as Measured by Intracoronary Ultrasound After Cardiac Transplantation
1995
Vascular Calcification
2004 Standout
Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study.
1991
Heart transplantation in AL amyloidosis
1995
Task force 5: Complications
1993
Relationship of Clinical Presentation and Calcification of Culprit Coronary Artery Stenoses
2001
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
2013
Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2001 Standout
Works of Valantine Ha being referenced
Recurrence of amyloid in a cardiac allograft four months after transplantation.
1989
Prevention and treatment of cytomegalovirus disease in thoracic organ transplant patients: evidence for a beneficial effect of hyperimmune globulin.
1995
Successful intermediate-term outcome for patients with cardiac amyloidosis undergoing heart transplantation: results of a multicenter survey.
1990
Incidence and progression of transplant coronary artery disease over 1 year: results of a multicenter trial with use of intravascular ultrasound. Multicenter Intravascular Ultrasound Transplant Study Group.
1996
Role of lipids in allograft vascular disease: a multicenter study of intimal thickening detected by intravascular ultrasound.
1996
Changes in Doppler echocardiographic indexes of left ventricular function as potential markers of acute cardiac rejection.
1987
Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients.
1995
Exercise echocardiography in heart transplant recipients: a comparison with angiography and intracoronary ultrasonography.
1994
Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens.
1989